SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Pharma stocks gain as new Covid variant takes focus

26 Nov 2021 Evaluate

Shares of pharmaceuticals and healthcare services are in demand, as investors shifted focus to pharma stocks amid the emergence of a new, highly mutated Covid-19 variant.

Cipla is currently trading at Rs. 964.15, up by 64.20 points or 7.13% from its previous closing of Rs. 899.95 on the BSE.

Alkem Laboratories is currently trading at Rs. 3556.00, up by 220.25 points or 6.60% from its previous closing of Rs. 3335.75 on the BSE.

Strides Pharma Science is currently trading at Rs. 517.10, up by 12.25 points or 2.43% from its previous closing of Rs. 504.85 on the BSE.

Cipla Share Price

1228.90 -9.40 (-0.76%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×